Literature DB >> 23461365

CYP19 gene variants affect the assisted reproduction outcome of women with polycystic ovary syndrome.

Leandros Lazaros1, Nectaria Xita, Elissavet Hatzi, Atsushi Takenaka, Apostolos Kaponis, Georgios Makrydimas, Nikolaos Sofikitis, Theodoros Stefos, Konstantinos Zikopoulos, Ioannis Georgiou.   

Abstract

OBJECTIVE: Cytochrome P450 aromatase catalyzes the irreversible transformation of androgens into estrogens. The association of CYP19(TTTA)n polymorphism with the hormonal profile and the assisted reproduction outcome of women with polycystic ovary syndrome (PCOS) was explored.
METHODS: One hundred and thirty-two women with PCOS and 200 with male-factor infertility, as controls, participated in the current study. The CYP19(TTTA)n polymorphism was genotyped, while the hormonal profile was determined at the third day of the menstrual cycle. During oocyte retrieval, the follicular size, the follicle and oocyte numbers were recorded.
RESULTS: Genotype analysis revealed 6 CYP19(TTTA)n alleles with 7-12 repeats. In PCOS women, the CYP19(TTTA)7 allele presence was associated with lower serum E2 levels at the third day of the menstrual cycle (p < 0.009), lower large follicle (p < 0.02) and total oocyte numbers (p = 0.006), but with significantly higher pregnancy rates after assisted reproduction (p < 0.004).
CONCLUSIONS: Potential associations of the CYP19(TTTA)7 allele with ovarian response to standard gonadotrophin stimulation and with assisted reproduction outcome were found in PCOS women, probably due to androgen/estrogen ratio alterations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23461365     DOI: 10.3109/09513590.2013.774359

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  8 in total

1.  Does elevated progesterone on day of oocyte maturation play a role in the racial disparities in IVF outcomes?

Authors:  Micah J Hill; G Donald Royster; Mansi Taneja; Mae Wu Healy; Shvetha M Zarek; Alicia Y Christy; Alan H DeCherney; Eric Widra; Kate Devine
Journal:  Reprod Biomed Online       Date:  2016-11-16       Impact factor: 3.828

Review 2.  A Review on CYP11A1, CYP17A1, and CYP19A1 Polymorphism Studies: Candidate Susceptibility Genes for Polycystic Ovary Syndrome (PCOS) and Infertility.

Authors:  Roozbeh Heidarzadehpilehrood; Maryam Pirhoushiaran; Rasoul Abdollahzadeh; Malina Binti Osman; Maryam Sakinah; Norshariza Nordin; Habibah Abdul Hamid
Journal:  Genes (Basel)       Date:  2022-02-05       Impact factor: 4.096

3.  The correlation of aromatase activity and obesity in women with or without polycystic ovary syndrome.

Authors:  Jie Chen; Shanmei Shen; Yong Tan; Dong Xia; Yanjie Xia; Yunxia Cao; Wenjun Wang; Xiaoke Wu; Hongwei Wang; Long Yi; Qian Gao; Yong Wang
Journal:  J Ovarian Res       Date:  2015-03-22       Impact factor: 4.234

Review 4.  Genetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology.

Authors:  Roshan Dadachanji; Nuzhat Shaikh; Srabani Mukherjee
Journal:  Genet Res Int       Date:  2018-02-18

5.  Therapeutic Effect of Ecklonia cava Extract in Letrozole-Induced Polycystic Ovary Syndrome Rats.

Authors:  Hyun Yang; Seung Yeon Lee; Sang R Lee; Bo-Jeong Pyun; Hye Jin Kim; Young Ho Lee; Sun Woo Kwon; Dong Ho Suh; Choong Hwan Lee; Eui-Ju Hong; Hye Won Lee
Journal:  Front Pharmacol       Date:  2018-11-19       Impact factor: 5.810

Review 6.  Identifying genes associated with the development of human polycystic ovary syndrome.

Authors:  Salina Y Saddick
Journal:  Saudi J Biol Sci       Date:  2020-01-16       Impact factor: 4.219

7.  The Associations of Androgen-Related Genes CYP21A2 and CYP19A1 with Severe Acne Vulgaris in Patients from Southwest China.

Authors:  Ting Yang; Wen-Juan Wu; Li-Ming Tian; Deng-Feng Zhang; Xiao-Yan Yang; Jue Qi; Ying Tu; Li He
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-03-29

Review 8.  The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis.

Authors:  Hiral Chaudhary; Jalpa Patel; Nayan K Jain; Rushikesh Joshi
Journal:  J Ovarian Res       Date:  2021-09-26       Impact factor: 4.234

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.